Vagal Motor Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The vagal motor neurons, primarily located in the dorsal motor nucleus of the vagus (DMV), provide parasympathetic innervation to visceral organs. These neurons are critically involved in autonomic regulation and are affected in several neurodegenerative diseases, particularly Parkinson's disease.
The dorsal motor nucleus of the vagus (DMV) is located in the medulla oblongata, in the floor of the fourth ventricle. It contains preganglionic parasympathetic neurons whose axons travel in the vagus nerve (cranial nerve X) to innervate postganglionic neurons in peripheral ganglia.
| Taxonomy |
ID |
Name / Label |
| Allen Brain Cell Atlas |
Search |
Vagal Motor Neurons |
| Cell Ontology (CL) |
Search |
Check classification |
| Human Cell Atlas |
Search |
Check expression data |
| CellxGene Census |
Search |
Check cell census |
- Cholinergic: Express choline acetyltransferase (ChAT)
- Peptidergic: Co-express vasoactive intestinal peptide (VIP), cholecystokinin (CCK)
- Nitroxidergic: Some neurons produce nitric oxide
- Tonic firing pattern at rest
- Receive synaptic input from nucleus of the solitary tract (NTS)
- Modulated by hypothalamic and limbic structures
- Control gastric motility and secretion
- Regulate pancreatic enzyme release
- Modulate intestinal peristalsis
- Influence gallbladder contraction
- Reduce heart rate (parasympathetic)
- Decrease cardiac contractility
- Modulate baroreflex
- Bronchoconstriction
- Regulation of bronchial secretions
- Esophagus (proximal)
- Stomach
- Pancreas
- Liver (partial)
- Lungs
- Heart (parasympathetic)
- Small intestine
- Large intestine (proximal)
- Kidneys (partial)
- Adrenal medulla
- DMV neurons contain alpha-synuclein inclusions in PD
- Loss of vagal preganglionic neurons observed
- Correlates with gastrointestinal symptoms
- Early target in Braak staging hypothesis
- GI symptoms as early PD markers
- Loss of vagal innervation as disease progression marker
- Potential for early intervention
- Neurofilament light chain as biomarker